Package | dk.kip.rkkp.fhir.ig.core |
Resource Type | ValueSet |
Id | ATCChemoPreparation |
FHIR Version | R4 |
Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/ValueSet-ATCChemoPreparation.html |
URL | https://kip.rkkp.dk/fhir/ValueSet/ATCChemoPreparation |
Version | 2.12.0 |
Status | active |
Date | 2022-06-14T00:00:00+02:00 |
Name | ATCChemoPreparation |
Title | ATC: Præparater for kemobehandling |
Description | ATC koder for præparater for kemobehandling |
No resources found
CodeSystem | |
ATC | WHO ATC |
GenericValues | Generic values |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet ATCChemoPreparation
This value set includes codes based on the following rules:
https://kip.rkkp.dk/fhir/CodeSystem/ATC
Code | Display | Definition |
L01BC02 | Fluorouracil (5-FU) | L01BC02 - Fluorouracil (5-FU) |
L01BC05 | Gemcitabine | L01BC02 - Gemcitabine |
L01BC06 | Capecitabine | L01BC06 - Capecitabine |
L01CA04 | Vinorelbine | L01CA04 - Vinorelbine |
L01CD01 | Paclitaxel | L01CD01 - Paclitaxel |
L01CD02 | Docetaxel | L01CD02 - Docetaxel |
L01CE02 | Irinotecan | L01CE02 - Irinotecan |
L01DB01 | Doxorubicin | L01DB01 - Doxorubicin |
L01DB03 | Epirubicin | L01DB03 - Epirubicin |
L01FD01 | Trastuzumab | L01FD01 - Trastuzumab |
L01FF01 | Nivolumab | L01FF01 - Nivolumab |
L01FF02 | Pembrolizumab | L01FF02 - Pembrolizumab |
L01FG01 | Bevacizumab | L01FG01 - Bevacizumab |
L01XA01 | Cisplatin | L01XA01 - Cisplatin |
L01XA02 | Carboplatin | L01XA02 - Carboplatin |
L01XA03 | Oxaliplatin | L01XA03 - Oxaliplatin |
S01LA08 | Bevacizumab | S01LA08 - Bevacizumab |
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues
Code | Display | Definition |
other | Andet | Other - used to choose unspecific value not in a valueset |
{ "resourceType": "ValueSet", "id": "ATCChemoPreparation", "text": { "status": "extensions", "div": "<!-- snip (see above) -->" }, "url": "https://kip.rkkp.dk/fhir/ValueSet/ATCChemoPreparation", "version": "2.12.0", "name": "ATCChemoPreparation", "title": "ATC: Præparater for kemobehandling", "status": "active", "experimental": true, "date": "2022-06-14T00:00:00+02:00", "publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "contact": [ { "name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "telecom": [ { "system": "url", "value": "https://trifork.com" }, { "system": "email", "value": "rbk@trifork.com" } ] } ], "description": "ATC koder for præparater for kemobehandling", "compose": { "include": [ { "system": "https://kip.rkkp.dk/fhir/CodeSystem/ATC", "concept": [ { "code": "L01BC02", "display": "Fluorouracil (5-FU)" }, { "code": "L01BC05", "display": "Gemcitabine" }, { "code": "L01BC06", "display": "Capecitabine" }, { "code": "L01CA04", "display": "Vinorelbine" }, { "code": "L01CD01", "display": "Paclitaxel" }, { "code": "L01CD02", "display": "Docetaxel" }, { "code": "L01CE02", "display": "Irinotecan" }, { "code": "L01DB01", "display": "Doxorubicin" }, { "code": "L01DB03", "display": "Epirubicin" }, { "code": "L01FD01", "display": "Trastuzumab" }, { "code": "L01FF01", "display": "Nivolumab" }, { "code": "L01FF02", "display": "Pembrolizumab" }, { "code": "L01FG01", "display": "Bevacizumab" }, { "code": "L01XA01", "display": "Cisplatin" }, { "code": "L01XA02", "display": "Carboplatin" }, { "code": "L01XA03", "display": "Oxaliplatin" }, { "code": "S01LA08", "display": "Bevacizumab" } ] }, { "system": "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues", "concept": [ { "code": "other", "display": "Andet" } ] } ] } }